Global Pharmacogenetics Testing in PsychiatryDepression Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,800	565 Pages	Data Bridge Market Research	February, 2024	DAABD18636647

Best Price Guarantee
Price	from $4,800
Length	565 Pages
Publisher	Data Bridge Market Research
Published Date	February, 2024
SKU	DAABD18636647

Global Pharmacogenetics Testing in PsychiatryDepression Market

The global pharmacogenetics testing in psychiatry/depression market is expected to reach USD 2,664,382.70 thousand by 2031 from USD 1,224,473.84 thousand in 2023, growing with a CAGR of 10.4% in the forecast period of 2024 to 2034.

Market Segmentation

Global Pharmacogenetics Testing in Psychiatry/Depression Market, By Type (Anxiety, Mood Disorders, Depression, Bipolar Disorders, Psychotic Disorders, and Eating Disorders), Test Type (Whole Genome Sequencing and Chromosomal Array-Based Tests), Patient Type (Child, Adults, and Geriatric), Gene Type (CYP2C19, CYP2C9 and VKORC1, CYP2D6, HLA-B, HTR2A/C, HLA-A, CYP3A4, SLC6A4, MTHFR, COMT, and Others), Products (Instruments, Consumables, and Software and Services), End User (Hospitals and Clinics, Diagnostics Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distribution, Hospital Pharmacy, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Turkey, Belgium, Netherlands, Switzerland, Denmark, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Indonesia, Philippines, Malaysia, New Zealand, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2031

Overview of Global Pharmacogenetics Testing in Psychiatry/Depression Market Dynamics

Driver
• Rising number of population suffering from depressive disorder

Restraint
• Insufficient clinical validation

Opportunity
• Advancements in genetic testing

Market Players

Some of the major market players operating in the global pharmacogenetics testing in psychiatry/depression market are listed below:
• ThermoFisher Scientific Inc. (U.S.)
• Illumina Inc. (U.S.)
• Myriad Genetics Inc. (U.S.)
• Sonic Healthcare Limited (Australia)
• QIAGEN (Germany)
• AB-BIOTICS S.A. (Spain)
• BiogeniQ Inc. (Canada)
• Castle Bioscience Inc. (U.S.)
• Coriell Life Sciences (U.S.)
• Dynamic DNA Laboratories (U.S.)
• Eurofins Scientific (Luxembourg)
• Genelex (U.S.)
• Genewiz (U.S.)
• Genomind Inc. (U.S.)
• GenXys (Canada)
• HealthSpek (U.S.)
• HudsonAlpha (U.S.)
• MD Labs (U.S.)
• ONEOME LLC (U.S.)
• PacBio (U.S.)

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Global Pharmacogenetics Testing In Psychiatry/Depression Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Market End User Coverage Grid; 2.8 Type Lifeline Curve; 2.9 Dbmr Market Position Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insight: 4.1 Pestal Analysis; 4.2 Porters Five Forces
5 Industrial Insights
6 Global Pharmacogenetics Testing In Psychiatry/Depression Market, Regulations: 6.1 U.S.; 6.2 European Union (Eu); 6.3 France; 6.4 Australia; 6.5 South Korea
7 Market Overview: 7.1 Drivers; 7.1.1 Rising Number Of Population Suffering From Depressive Disorder; 7.1.2 Initiatives Taken By Manufacturers Due To Genetic Variability; 7.1.3 Growing Biotechnology Sector Along With Rising Healthcare Expenditure; 7.1.4 Increasing Interest For Personalized And Precision Medication; 7.2 Restraints; 7.2.1 Insufficient Clinical Validation; 7.2.2 Stigma And Perception For Mental Health; 7.2.3 Lack Of Reimbursement; 7.3 Opportunities; 7.3.1 Advancements In Genetic Testing; 7.3.2 Emerging Start-ups Branches Innovation; 7.3.3 Reduced Healthcare Costs Through The Implementation Of Cost-saving Measures; 7.4 Challenges; 7.4.1 Rising Concern Regarding Data Privacy And Security; 7.4.2 Shortage Of Skilled Healthcare Professionals
8 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Product: 8.1 Overview; 8.2 Consumables; 8.3 Instruments; 8.4 Software And Services
9 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type: 9.1 Overview; 9.2 Whole Genome Sequencing; 9.3 Chromosomal Array Based Tests
10 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Type: 10.1 Overview; 10.2 Anxiety; 10.3 Depression; 10.4 Mood Disorders; 10.5 Bipolar Disorders; 10.6 Eating Disorders; 10.7 Psychotic Disorders
11 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Gene Type: 11.1 Overview; 11.2 Cyp2c19; 11.3 Cyp2c9 And Vkorc1; 11.4 Cyp2d6; 11.5 Hla-b; 11.6 Htr2a/C; 11.7 Hla-a; 11.8 Cyp3a4; 11.9 Slc6a4; 11.10 Mthfr; 11.11 Comt; 11.12 Others
12 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Patient Type: 12.1 Overview; 12.2 Adult; 12.3 Geriatric; 12.4 Child
13 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By End User: 13.1 Overview; 13.2 Hospital And Clinics; 13.3 Diagnostics Laboratories; 13.4 Academic And Research Institutes; 13.5 Others
14 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Distribution Channel: 14.1 Overview; 14.2 Direct Tender; 14.3 Third Party Distribution; 14.4 Hospital Pharmacy; 14.5 Others
15 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Region: 15.1 Overview; 15.2 North America; 15.2.1 U.S.; 15.2.2 Canada; 15.2.3 Mexico; 15.3 Europe; 15.3.1 Germany; 15.3.2 France; 15.3.3 U.K.; 15.3.4 Italy; 15.3.5 Russia; 15.3.6 Spain; 15.3.7 Turkey; 15.3.8 Netherlands; 15.3.9 Switzerland; 15.3.10 Poland; 15.3.11 Hungary; 15.3.12 Austria; 15.3.13 Norway; 15.3.14 Ireland; 15.3.15 Lithuania; 15.3.16 Rest Of Europe; 15.4 Asia-pacific; 15.4.1 Japan; 15.4.2 China; 15.4.3 South Korea; 15.4.4 India; 15.4.5 Australia; 15.4.6 Singapore; 15.4.7 Thailand; 15.4.8 Malaysia; 15.4.9 Indonesia; 15.4.10 Philippines; 15.4.11 Vietnam; 15.4.12 Rest Of Asia-pacific; 15.5 Middle East And Africa; 15.5.1 South Africa; 15.5.2 Saudi Arabia; 15.5.3 U.A.E.; 15.5.4 Israel; 15.5.5 Egypt; 15.5.6 Rest Of Middle East And Africa; 15.6 South America; 15.6.1 Brazil; 15.6.2 Argentina; 15.6.3 Peru; 15.6.4 Rest Of South America
16 Global Pharmacogenetics Testing In Psychiatry/Depression Market: Company Landscape: 16.1 Company Share Analysis: Global; 16.2 Company Share Analysis: North America; 16.3 Company Share Analysis: Europe; 16.4 Company Share Analysis: Asia-pacific
17 Swot Analysis
18 Company Profiles: 18.1 Thermo Fisher Scientific Inc.; 18.1.1 Company Snapshot; 18.1.2 Recent Financials; 18.1.3 Company Share Analysis; 18.1.4 Product Portfolio; 18.1.5 Recent Development; 18.2 Illumina, Inc.; 18.2.1 Company Snapshot; 18.2.2 Revenue Analysis; 18.2.3 Company Share Analysis; 18.2.4 Product Portfolio; 18.2.5 Recent Developments; 18.3 Myriad Genetics, Inc.; 18.3.1 Company Snapshot; 18.3.2 Revenue Analysis; 18.3.3 Company Share Analysis; 18.3.4 Product Portfolio; 18.3.5 Recent Developments; 18.4 Sonic Healthcare Limited; 18.4.1 Company Snapshot; 18.4.2 Revenue Analysis; 18.4.3 Company Share Analysis; 18.4.4 Product Portfolio; 18.4.5 Recent Development; 18.5 Qiagen; 18.5.1 Company Snapshot; 18.5.2 Revenue Analysis; 18.5.3 Company Share Analysis; 18.5.4 Product Portfolio; 18.5.5 Recent Developments; 18.6 Ab-biotics, S.A.; 18.6.1 Company Snapshot; 18.6.2 Product Portfolio; 18.6.3 Recent Developments; 18.7 Biogeniq Inc.; 18.7.1 Company Snapshot; 18.7.2 Product Portfolio; 18.7.3 Recent Development; 18.8 Castle Bioscience, Inc.; 18.8.1 Company Snapshot; 18.8.2 Revenue Analysis; 18.8.3 Product Portfolio; 18.8.4 Recent Developments; 18.9 Coriell Life Sciences; 18.9.1 Company Snapshot; 18.9.2 Product Portfolio; 18.9.3 Recent Developments; 18.10 Dynamic Dna Laboratories; 18.10.1 Company Snapshot; 18.10.2 Product Portfolio; 18.10.3 Recent Development; 18.11 Eurofins Scientific; 18.11.1 Company Snapshot; 18.11.2 Revenue Analysis; 18.11.3 Product Portfolio; 18.11.4 Recent Developments; 18.12 Genelex (Subsiadiary Of Invitae Corporation.); 18.12.1 Company Snapshot; 18.12.2 Revenue Analysis; 18.12.3 Product Portfolio; 18.12.4 Recent Development; 18.13 Genewiz (Part Of Azenta Life Sciences); 18.13.1 Company Snapshot; 18.13.2 Revenue Analysis; 18.13.3 Product Portfolio; 18.13.4 Recent Development; 18.14 Genomind, Inc.; 18.14.1 Company Snapshot; 18.14.2 Product Portfolio; 18.14.3 Recent Developments; 18.15 Genxys; 18.15.1 Company Snapshot; 18.15.2 Product Portfolio; 18.15.3 Recent Developments; 18.16 Healthspek; 18.16.1 Company Snapshot; 18.16.2 Product Portfolio; 18.16.3 Recent Development; 18.17 Hudsonalpha; 18.17.1 Company Snapshot; 18.17.2 Product Portfolio; 18.17.3 Recent Development; 18.18 Md Labs; 18.18.1 Company Snapshot; 18.18.2 Product Portfolio; 18.18.3 Recent Development; 18.19 Oneome, Llc; 18.19.1 Company Snapshot; 18.19.2 Product Portfolio; 18.19.3 Recent Developments; 18.20 Pacbio; 18.20.1 Company Snapshot; 18.20.2 Revenue Analysis; 18.20.3 Product Portfolio; 18.20.4 Recent Developments 559
19 Questionnaire
20 Related Reports
List Of Tables: Table 1 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 2 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units); Table 3 Global Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 4 Global Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 5 Global Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units); Table 6 Global Instruments In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 7 Global Software And Services In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 8 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 9 Global Whole Genome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 10 Global Whole Genome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 11 Global Exome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 12 Global Karyotype In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 13 Global Low Coverage Wgs In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 14 Global Deep Coverage Wgs In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 15 Global Microarray In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 16 Global Chromosomal Array Based Tests In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 17 Global Chromosomal Array Based Tests In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 18 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Type, 2022-2031 (Usd Thousand); Table 19 Global Anxiety In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 20 Global Depression In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 21 Global Mood Disorders In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 22 Global Bipolar Disorders In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 23 Global Eating Disorders In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 24 Global Psychotic Disorders In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 25 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Gene Type, 2022-2031 (Usd Thousand); Table 26 Global Cyp2c19 In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 27 Global Cyp2c9 And Vkorc1 In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 28 Global Cyp2d6 In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 29 Global Hla-b In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 30 Global Htr2a/C In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 31 Global Hla-a In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 32 Global Cyp3a4 In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 33 Global Slc6a4 In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 34 Global Mthfr In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 35 Global Comt In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 36 Global Others In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 37 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Patient Type, 2022-2031 (Usd Thousand); Table 38 Global Adult In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 39 Global Geriatric In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 40 Global Child In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 41 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 42 Global Hospital And Clinics In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 43 Global Hospital And Clinics In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 44 Global Diagnostics Laboratories In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 45 Global Diagnostics Laboratories In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 46 Global Academic And Research Institutes In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 47 Global Academic And Research Institutes In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 48 Global Others In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 49 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 50 Global Direct Tender In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 51 Global Third Party Distribution In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 52 Global Hospital Pharmacy In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 53 Global Others In Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 54 Global Pharmacogenetics Testing In Psychiatry/Depression Market, By Region, 2022-2031 (Usd Thousand); Table 55 North America Pharmacogenetics Testing In Psychiatry/Depression Market, By Country, 2022-2031 (Usd Thousand); Table 56 North America Pharmacogenetics Testing In Psychiatry/Depression Market, By Type, 2022-2031 (Usd Thousand); Table 57 North America Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 58 North America Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units); Table 59 North America Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 60 North America Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units); Table 61 North America Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 62 North America Whole Genome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 63 North America Exome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 64 North America Karyotype In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 65 North America Low Coverage Wgs In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 66 North America Deep Coverage Wgs In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 67 North America Microarray In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 68 North America Chromosomal Array Based Tests In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 69 North America Pharmacogenetics Testing In Psychiatry/Depression Market, Gene Type, 2022-2031 (Usd Thousand); Table 70 North America Pharmacogenetics Testing In Psychiatry/Depression Market, By Patient Type, 2022-2031 (Usd Thousand); Table 71 North America Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 72 North America Hospital And Clinics In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 73 North America Diagnostics Laboratories In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 74 North America Academic And Research Institutes In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 75 North America Pharmacogenetics Testing In Psychiatry/Depression Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 76 U.S. Pharmacogenetics Testing In Psychiatry/Depression Market, By Type, 2022-2031 (Usd Thousand); Table 77 U.S. Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 78 U.S. Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units); Table 79 U.S. Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Asp (Usd); Table 80 U.S. Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 81 U.S. Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units); Table 82 U.S. Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Asp (Usd); Table 83 U.S. Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 84 U.S. Whole Genome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 85 U.S. Exome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 86 U.S. Karyotype In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 87 U.S. Low Coverage Wgs In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 88 U.S. Deep Coverage Wgs In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 89 U.S. Microarray In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 90 U.S. Chromosomal Array Based Tests In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 91 U.S. Pharmacogenetics Testing In Psychiatry/Depression Market, Gene Type, 2022-2031 (Usd Thousand); Table 92 U.S. Pharmacogenetics Testing In Psychiatry/Depression Market, By Patient Type, 2022-2031 (Usd Thousand); Table 93 U.S. Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 94 U.S. Hospital And Clinics In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 95 U.S. Diagnostics Laboratories In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 96 U.S. Academic And Research Institutes In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 97 U.S. Pharmacogenetics Testing In Psychiatry/Depression Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 98 Canada Pharmacogenetics Testing In Psychiatry/Depression Market, By Type, 2022-2031 (Usd Thousand); Table 99 Canada Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 100 Canada Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units); Table 101 Canada Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Asp (Usd); Table 102 Canada Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 103 Canada Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units); Table 104 Canada Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Asp (Usd); Table 105 Canada Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 106 Canada Whole Genome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 107 Canada Exome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 108 Canada Karyotype In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 109 Canada Low Coverage Wgs In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 110 Canada Deep Coverage Wgs In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 111 Canada Microarray In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 112 Canada Chromosomal Array Based Tests In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 113 Canada Pharmacogenetics Testing In Psychiatry/Depression Market, Gene Type, 2022-2031 (Usd Thousand); Table 114 Canada Pharmacogenetics Testing In Psychiatry/Depression Market, By Patient Type, 2022-2031 (Usd Thousand); Table 115 Canada Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 116 Canada Hospital And Clinics In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 117 Canada Diagnostics Laboratories In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 118 Canada Academic And Research Institutes In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 119 Canada Pharmacogenetics Testing In Psychiatry/Depression Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 120 Mexico Pharmacogenetics Testing In Psychiatry/Depression Market, By Type, 2022-2031 (Usd Thousand); Table 121 Mexico Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 122 Mexico Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units); Table 123 Mexico Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Asp (Usd); Table 124 Mexico Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 125 Mexico Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units); Table 126 Mexico Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Asp (Usd); Table 127 Mexico Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 128 Mexico Whole Genome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 129 Mexico Exome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 130 Mexico Karyotype In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 131 Mexico Low Coverage Wgs In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 132 Mexico Deep Coverage Wgs In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 133 Mexico Microarray In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 134 Mexico Chromosomal Array Based Tests In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 135 Mexico Pharmacogenetics Testing In Psychiatry/Depression Market, Gene Type, 2022-2031 (Usd Thousand); Table 136 Mexico Pharmacogenetics Testing In Psychiatry/Depression Market, By Patient Type, 2022-2031 (Usd Thousand); Table 137 Mexico Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 138 Mexico Hospital And Clinics In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 139 Mexico Diagnostics Laboratories In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 140 Mexico Academic And Research Institutes In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 141 Mexico Pharmacogenetics Testing In Psychiatry/Depression Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 142 Europe Pharmacogenetics Testing In Psychiatry/Depression Market, By Country, 2022-2031 (Usd Thousand); Table 143 Europe Pharmacogenetics Testing In Psychiatry/Depression Market, By Type, 2022-2031 (Usd Thousand); Table 144 Europe Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 145 Europe Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units); Table 146 Europe Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 147 Europe Consumables In Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units); Table 148 Europe Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 149 Europe Whole Genome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 150 Europe Exome Sequencing In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 151 Europe Karyotype In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 152 Europe Low Coverage Wgs In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 153 Europe Deep Coverage Wgs In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 154 Europe Microarray In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 155 Europe Chromosomal Array Based Tests In Pharmacogenetics Testing In Psychiatry/Depression Market, By Test Type, 2022-2031 (Usd Thousand); Table 156 Europe Pharmacogenetics Testing In Psychiatry/Depression Market, Gene Type, 2022-2031 (Usd Thousand); Table 157 Europe Pharmacogenetics Testing In Psychiatry/Depression Market, By Patient Type, 2022-2031 (Usd Thousand); Table 158 Europe Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 159 Europe Hospital And Clinics In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 160 Europe Diagnostics Laboratories In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 161 Europe Academic And Research Institutes In Pharmacogenetics Testing In Psychiatry/Depression Market, By End User, 2022-2031 (Usd Thousand); Table 162 Europe Pharmacogenetics Testing In Psychiatry/Depression Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 163 Germany Pharmacogenetics Testing In Psychiatry/Depression Market, By Type, 2022-2031 (Usd Thousand); Table 164 Germany Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 (Usd Thousand); Table 165 Germany Pharmacogenetics Testing In Psychiatry/Depression Market, By Product, 2022-2031 Volume (Units)